Aamir Malik is Executive Vice President, Chief Business Innovation Officer, responsible for the company’s strategy, business development, portfolio management, pipeline prioritization and formation of new business ventures, as well as the advancement of innovative access partnerships with payers and governments around the world.
Prior to joining Pfizer, Aamir was the Managing Partner of McKinsey & Company’s United States operations and previously led the firm’s Global Pharmaceutical and Medical Products Practice. In his 25 years at McKinsey, Aamir developed innovative growth strategies, guided mergers and acquisitions and implemented high-impact programs to improve patients’ lives and transform performance for life science companies. He has advised many Boards, CEOs and top management teams in the life science space.
Aamir earned a Bachelor of Science in finance from Indiana University and currently serves on the University’s Kelly School of Business Dean’s Council. He is an active advocate for bettering the lives of people with food allergies and has lived and worked globally, including in the United States, Europe, Asia, Latin America and Africa.